Yayınlar & Eserler

Yayın Ağı
Makaleler 4
Tümü (4)
SCI-E, SSCI, AHCI (3)
SCI-E, SSCI, AHCI, ESCI (4)
ESCI (1)
Scopus (4)
TRDizin (1)

1. Quinazoline-4(3 H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition

Turanll S., Ergül A. G., Jordan P. M., OLĞAÇ A., Çallşkan B., Werz O., et al.
ACS Omega , cilt.7, sa.41, ss.36354-36365, 2022 (SCI-Expanded, Scopus) identifier identifier

2. Novel potent benzimidazole-based microsomal prostaglandin E-2 synthase-1 (mPGES-1) inhibitors derived from BRP-201 that also inhibit leukotriene C-4 synthase

Ergul A. G., GÜR MAZ Z. T., Kretzer C., OLĞAÇ A., Jordan P. M., ÇALIŞKAN B., et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , cilt.231, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier identifier

3. Synthesis of novel potential ROCK inhibitors and their antimigratory effects

Turanli S., Uslu A. G., ÖZDEMİR A.
ORGANIC COMMUNICATIONS , cilt.13, sa.4, ss.165-174, 2020 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

4. Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors

Uslu A. G., GÜR MAZ Z. T., Nocentini A., BANOĞLU E., Supuran C. T., ÇALIŞKAN B.
BIOORGANIC CHEMISTRY , cilt.95, 2020 (SCI-Expanded, Scopus) identifier identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. A journey from selective FLAP inhibitor to selective mPGES-1 inhibitor: A new therapeutic modality for reducing inflammation and pain

Ergül A. G., Banoğlu E., Çalışkan B., Gür Maz Z. T., Olğaç A.
8Th International BAU Drug Design Congress, İstanbul, Türkiye, 15 - 17 Aralık 2022, ss.1, (Özet Bildiri)

2. NOVEL MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 (mPGES-1) INHIBITOR AS A NEW MODALITY TO TREAT INFLAMMATION

Çalışkan B., Ergül A. G., Gür Maz Z. T., Olğaç A., Banoğlu E.
EFMC-ISMC 2022 - XXVII EFMC International Symposium on Medicinal Chemistry, Nice, Fransa, 4 - 08 Eylül 2022, ss.321, (Özet Bildiri) Sürdürülebilir Kalkınma

3. EVALUATION OF OXADIAZOLE DERIVATIVES AS PROMISING MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 (mPGES-1) INHIBITORS

Gür Maz Z. T., Ergül A. G., Çalışkan B., Banoğlu E.
EFMC-ISMC 2022 - XXVII EFMC International Symposium on Medicinal Chemistry, Nice, Fransa, 4 - 09 Eylül 2022, ss.355, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Investigation of the antimigratory activity of 2-aminothiazole derivative compound in two different cancer cells

Şimay Demir Y. D., Ergül A. G.
9th International Academic Studies Conference, 3 - 05 Ağustos 2022, ss.263-264, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Selective or Dual Inhibitors of Inflammatory PGE2 and LTB4 Biosynthesis by Targeting mPGES-1 And FLAP to Intervene with Inflammatory Deregulation

BANOĞLU E., ÇALIŞKAN B., ERGÜL A. G., GÜR MAZ Z. T., OLĞAÇ A., WERZ O.
The 6th International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS-6), Gaziantep, Türkiye, 26 - 28 Mayıs 2022, (Özet Bildiri)

6. Discovery of Novel Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors: A New Modality to Treat Inflammation

Banoğlu E., Çalışkan B., Ergül A. G., Gür Maz Z. T., Olğaç A.
10.International Drug Chemistry Conference, Antalya, Türkiye, 10 - 13 Mart 2022, ss.12, (Özet Bildiri) Sürdürülebilir Kalkınma